Scientists test new Auto-Injector version of skin condition drug
Knowledge-focused
Not yet recruiting
This early-stage study aims to compare how the body processes CT-P52 (a biosimilar version of the drug Taltz) when given through an auto-injector versus a traditional pre-filled syringe. The study will involve 218 healthy male volunteers who will receive a single dose and be moni…
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC